in an 8% DY decrease per 100 nmol/mL plasma LNAA in crease within the observed range of 330 to 510 nmollmL. This was similar to recent noninvasive observations with FDOPA PET in vervet monkeys and with 6-[F-181Fluoro-m-tyrosine PET in squirrel monkeys. The OMFD striatum to cerebellum (Str/Cb) ratio was greater than 1.0 for all measurements, aver aging 1.09 ± 0.04, and was approximately equal to the Str/Cb LNAA ratio of 1.12 ± 0.05. This current study verifies the variation of DY of OMFD or FDOPA as a function of plasma LNAA concentrations and suggests the possibility of using OMFD for measuring cerebral LNAA noninvasively with PET.
Summary:
The distribution volume (DY) of 6-[F-181tluoro L-DOPA (FDOPA) in the cerebellum recently has been linked using positron emission tomography (PET) to plasma large neutral amino acid (LNAA) concentrations in monkeys. In this article the authors provide additional experimental support for this relation by directly measuring the DY as the steady-state tissue to plasma radioactivity ratio in rats using a labeled LNAA analog 3-0-methyl-6-[F-18]FDOPA (OMFD), a com pound that has no known specific enzyme or receptor interac tions in brain tissue. The measured DY for OMFD (tissue OMFD concentration/plasma OMFD concentration) was found to be inversely related to plasma LNAA concentrations. The relation (DY = 1.5-0.00094* [LNAA] , R"2 = 0.79) resulted Recent observations with positron emission tomogra phy (PET) in vervet monkey demonstrated that the dis tribution volume (DV) of 6- [F-18] fluoro-L-DOPA (FDOPA) was inversely related to the plasma large neu tral amino acid (LNAA) concentrations (Stout et ai., 1998) . This finding has also been observed in squirrel monkey PET studies using FDOP A and for an amino acid analog, 6-[F-18]Fluoro-m-tyrosine (Stout et ai, 2000) . A simple explanation has been offered to account for this effect (Huang et ai., 1998) : the transport of LNAA between plasma and tissue is limited by satura tion of the transporter system (Smith et ai., 1987) and the DV of a labeled LNAA is a function of LNAA levels that are dependent on the apparent half-saturation con centra-tion of the transporter (Km app )' This effect provides a simple way in which the brain LNAA concentrations can be maintained at a fairly constant level. This mechanism is crucial, because plasma LNAA concentrations are known to vary significantly with diet (Fernstrom et ai., 1979; Voog and Ericksson, 1992a) , over the course of the day (Wurtman et aI., 1968; Voog and Eriksson, 1992b) and among subjects (Scriver et aI., 1985) .
The current study measures directly the DV in rat brain of a labeled LNAA as a function of plasma LNAA concentrations using the amino acid analogue 3-0methyl-6-[F-18]Fluoro-L-DOPA (OMFD). Other inves tigations have shown that OMFD, a major peripheral metabolite of FDOPA, uses the same LNAA transport system and has no apparent specific enzymatic or recep tor interactions within the brain (Doudet et ai., 199 1; Wahl et ai., 1994) . Therefore, tissue DV of OMFD can be directly determined in both striatum and cerebellum when both tissue and plasma concentrations approach constant levels. These measurements can be used to fur ther support the proposed blood-brain barrier (BBB) saturation mechanism that explains the variation of DV of a labeled inert LNAA as a function of the plasma LNAA level (Huang et aI., 1998) .
In addition, the combination of multiple pairs of tissue and plasma LNAA concentrations, together with the OMFD DV, allowed estimation of LNAA transport con stants (Km app ) for plasma and tissue. The Km app values obtained were then compared with those obtained by other means (Huang et aI., 1998) . The result shows that a consistent Km app value can potentially be used in com bination with OMFD DV measurements from PET data and plasma LNAA concentrations to estimate tissue LNAA concentrations in vivo. These findings and their implications are also discussed.
MATERIALS AND METHODS
Fifteen male Sprague -Dawley rats were divided into 5 groups (n = 3) and allowed free access to food for 1 week before experiments. Approximately 16 hours before the experi ments, animals were given free access overnight to diets con sisting of either 0% (fasted), 16%, 24%, 35%, or 45% protein diets. The 16% and 24% protein diets were commercially avail able (Teklad, Madison, WI, U.S.A.). The 35% and 45% diets were produced by adding casein (Sigma, St. Louis, MO, U.S.A.) to crushed 24% protein pellets, mixed with a small amount of water and dried into pellets.
Synthesis of OMFD followed a previously published method (Adam et ai., 1994) with minor modifications (radiochemical purity >99%). Rats were consciously injected with OMFD through tail vein at 10 to II in the morning. Blood samples were withdrawn and plasma radioactivity determined in a gamma well counter at 60 minutes postinjection, when plasma OMFD values approached a constant level (see below). Plasma samples were deproteinated with an equal volume of 0.8 moUL perchloric acid, filtered, and stored at -4°C for later LNAA analysis. After blood sampling, the animals were immediately decapitated and the striatum and cerebellum tissues were re moved and immediately frozen in liquid nitrogen. After weigh ing and well counting, tissues were homogenized in an equal volume of 0.8 mollL perchloric acid by glass rod and sonicated for 30 seconds. The slurry was filtered (0.22 micron) and stored at -4°C for subsequent LNAA analysis.
The percentage of plasma radioactivity due to un metabolized OMFD at 60 minutes was determined in 4 rats by HPLC (C-18 column, I mLimin, 80% 0.1 moUL NaH2P04, 2.6 mmollL octane sulfonic acid sodium salt, 0.1 mmol/L EDT A, pH 3.1, 20% methanol). In I rat, plasma samples were drawn at 30minute intervals for 2 hours to characterize the rate of metabo lite formation and to support the notion that plasma OMFD had reached a stable value at 60-minute postinjection. The effect of L-( -)-alpha-hydrazino-3,4-dihydroxy-alpha-methy Ihydrocin namic acid monohydrate (carbidopa) administration on me tabolite formation was examined in three additional rats. Car bidopa was administered (10 mg/kg, IP) 30 minutes before OMFD injection and metabolite formation was determined at 15-minute intervals for 2 hours in one rat and at 60 and 120 minutes in all 3 rats.
Quantification of LNAA concentrations in tissue and plasma was determined based on previously published methods (Keen et ai., 1989; Stout et aI., 1998) . In brief, samples were partially neutralized with an equal volume of 0.3 maUL potassium hy droxide, chilled for 5 minutes, and filtered. Equal volumes of sample and o-phthaldialdehyde (I mg/mL, Sigma) were mixed, incubated for 2 minutes, and injected onto a C-18 HPLC col umn (Beckman Instruments, Fullerton, CA, U.S.A.) at 0.8 mLi 
Estimates of Km ��,�"" a were also calculated from individual LNAA concentrations [AAJk (Huang et aI., 1998) using previ ously published individual Kmk values for conscious rats (Miller et aI., 1985) as (3) The 
The contribution of OMFD diffusion across the BBB could potentially contribute a significant fraction of the BBB trans port. Therefore, the authors estimated the diffusion fraction for OMFD transport using a modification of Eq. 2, in which a non saturable diffusion ternl was added to the forward and re verse transport of OMFD. With the addition of the diffusion term, the distribution volume of OMFD would be
where Vm and Km are the maximal rate and half saturation constants for carrier-mediated transport across the BBB, and Kd is the diffusion rate. Superscripts indicate whether the value is for tissue or plasma. Using Eq. 3, and assuming that (V,�K,�;)/ (V�K�.) =1, the above equation can be rearranged to
In this form, the diffusion component, Kd*(KmlVm), in the equation represents the fraction of OMFD transported through diffusion when there is zero competition (that is, [LNAAJ = 0). The equation was further constrained by assuming this dif fusion fraction was equal for forward and reverse transport and by fixing Km ���'ma to the estimated value of 84.3 nmollmL. Estimates of Km �;�,ue and the diffusion fraction were then obtained in striatum by fitting the directly measured DV OMFO with Eq. 6.
RESULTS

OMFD metabolism
Plasma OMFD concentration values were relatively constant (±3.5%) over the range of 30 to 120 minutes -----600 on ;:::, after injection. A metabolite was evident in the plasma HPLC data that was formed at a nearly linear rate of 17.3% ± 3.2% per hour (R"2 = 0.92; Fig. 1 ). Similar metabolite formation was observed with carbidopa (10.0% ± 5.3% per hour), indicating that the OMFD metabolism was not significantly affected (P > 0. 1) by inhibition of peripheral aromatic amino acid decarbox ylase (AAAD). The single metabolite was consistent with sulfate conjugates (Meleg a et a!., 199 1), which be cause of its charged nature is not known to cross the BBB (Doudet et a!., 199 1; Wahl et a!.. 1994). Because the hydrophilic metabolite remains in the bloodstream and does not cross the BBB through the LNAA transporter, the metabolite fraction was subtracted from the plasma radioactivity for determination of the plasma input func tion used in subsequent data analysis.
In tissue, only a single peak corresponding to OMFD and no metabolite fraction was observed. The authors' detection system was sufficiently sensitive to pick up the metabolite fraction if it were present at levels similar to that in plasma (10% to 17%). Trace quantities of the metabolite may have been present but below the level of detection.
Striatum and cerebellum distribution volume data
Striatum and cerebellum tissue LNAA concentrations remained unchanged over the measured range of plasma LNAA concentrations (Fig. 2) . The average striatum LNAA concentration (457 ± 40 nmol/mL; Table I ) was significantly higher (12%, t-test, P < 0.0 1) than cerebel lum concentrations (average 402 ± 34 nmol/mL). Stria tum to cerebellum ratios for all experiments were greater than 1.0 ( Fig. 3A) and were consistent with having a normal distribution (W-test, a = 0. 1, Wadsworth, 1990) . No significant difference between OMFD (1.09 ± 0.04) and LNAA (1.12 ± 0.05) Str/Cb ratios (Hest, P > 0.1) was found, and the two measurements were closely cor related (DV OMFD = 0.042 + 0.9 1 DV LNAA, r = 0.82). Because alterations in plasma LNAA were not matched by corresponding tissue concentration variations (Fig. 2) , DVs of OMFD CEq. 1) were inversely related to plasma LNAA concentrations in both striatum and cerebellum ( Fig. 3B and 3C , as expected according to Eq. 2). Using individual LNAA Km values for conscious rats (Miller et aI., 1985) and measured plasma LNAA con centrations, a Km !,��'m a value of 84.3 ± 2.5 nmol/mL was estimated based on Eq. 3. Fitting results for KmJ��, ue from Eq. 2 using Km !,�� s m a fixed to 84.3 and summed LNAA concentrations resulted in a striatum Km J ��'u c value of 65.9 ± 1.9 nmol/mL (R"2 = 0.7 1), which was 7% higher than the cerebellum value of 61.6 ± 1.6 nmoll mL. Estimates of OMFD Km !,�,;m a and Km J� � ,ue using Eq. 2 without constraining the Km :��"n a resulted in higher and more variable estimates (striatum: Km !,��;' m a 146 ± 157 nmol/mL, Km � ��,ue 116 ± 129; cerebellum: Km !,��'m a 70 ± 114, Km���,ue 51 ± 85 narrow range of LNAA concentrations and small number of animals probably contributed to the large variability in the unconstrained estimates.
Estimation of LNAA tissue concentrations
Tissue LNAA concentrations were estimated from Eq. 4 using OMFD concentrations in plasma and tissues and plasma LNAA concentrations, Km !,��'m a value of 84.3 nmollmL and Km ��� s ue of either 65.9 nmol/mL for stria tum or 61.6 nmol/mL for cerebellum. Estimates of tissue LNAA concentrations (Table 2) did not significantly dif fer from the measured LNAA concentrations (t-test, P > 0. 1) in either striatum or cerebellum; however, the indi vidual estimates were poorly correlated with their re spective measured values (r = 0.0]). The average abso lute difference between the estimated and measured mea surements was 10% ± 9% for striatum and 12% ± 9% for cerebellum.
Diffusion contribution
The addition of a diffusion component to account for inward and outward movement of OMFD across the BBB resulted in only minor changes in the estimated Km � ��su c ( Table 3) Plasma LNAA Concentration (nmolfmL)
. The diffusion component term (Kd
Fraction) was estimated as 0.0053 ± 0.0186, which is not significantly different from zero (F-test). Similar results were obtained for data in the cerebellum (Table 3) . Ex amination of the residual sum of squares by F-test showed that the addition of the diffusion component did not significantly change the fitting results for striatum or cerebellum data, indicating that the present data are con sistent with the notion of an insignificant amount of non saturable OMFD diffusion across the BBB at normal plasma LNAA conditions.
DISCUSSION
The agreement of OMFD DV data with previous re sults, using a variety of methods and amino acids (Fig.  4) , strengthens the validity of DV variability of labeled LNAA in the brain. In addition, the inert nonspecific uptake of OMFD allowed DV measurements in the stria tum, which were not possible in FDOP A experiments because of accumulation of its AAAD-dependent prod uct, 6-[F-18]fluorodopamine. Estimates of the diffusion fraction showed that the addition of the diffusion component did not significantly alter the estimates of Km ���sue . Previous work (Miller et aI., 1985) suggested that diffusion could play a signifi cant role with LNAA concentrations over 100 /-LmoIlL, whereas others have indicated diffusion becomes signifi cant only at concentrations over lO mmollL (Smith et aI., 1987) . The current results (Fig. 4) were consistent with those reported by Smith et aI. (1987) , in which the dif fusion component was determined to be insignificant at normal physiologic LNAA concentrations. The current data regarding DV OMFD also appear to be consistent with the literature values shown in Fig. 4 , in which DVs from previous studies were calculated without including the diffusion component (Huang et aI., 1998) .
Tryptophan is the only LNAA that binds to albumin, and some controversy exists over whether the total or unbound fraction should be used to determine the con centration available for competition with other LNAA (Salter et aI., 1989; Pardridge, 1977) . The authors chose to use the total plasma tryptophan concentration because it has been shown that the albumin-bound fraction will readily dissociate in brain capillaries and become avail able for transport across the BBB (Pardridge, 1990; Par dridge and Fierer, 1990) . In the authors' experiments, tryptophan levels were very consistent, averaging 12% ± 1 % of the total LNAA concentration. Also, because the authors do not expect large changes in the free:bound ratio among the animals resulting from the dietary con ditions used, the current data are unlikely to be affected by the exclusion of a bound tryptophan component.
Tissue LNAA concentrations remained fairly constant over a range of plasma LNAA concentrations, which was similar to previous investigations in rats (Glanville and Anderson, 1985; Meloche and Smith, 1995) . With LNAA levels affected little by plasma LNAA concen trations, an inverse correlation was observed between Fig. 4 ). The OMFD DV so determined matched well with previous data in rats and monkeys (Huang et aI., 1998; Stout et aI., 1998) and closely followed Michaelis-Menten transporter kinetics. The constant LNAA tissue levels also resulted in little change in Str/Cb ratios of both OMFD and LNAA over the observed range of plasma LNAA concentrations (Table I) because both striatum and cerebellum OMFD levels are affected in the same way by plasma LNAA variations. The use of a bolus injection raises the issue of whether a steady-state or constant OMFD level was achieved and present at the current 60-minute sampling time. The au thors examined this issue by creating a simulated OMFD input function and estimating DV OMFD values using pub lished transport rate constants (Wahl et aI., 1994) . Vary ing the late time plasma OMFD values (30 to 120 min utes) by ±20% resulted in less than a 5% change in the DVOMFD values, indicating that OMFD measurements at 60 minutes are reliable for estimating DV OMFD'
Variations in plasma LNAA levels could potentially affect the clearance of plasma OMFD and affect the con stancy of plasma OMFD at 60 minutes, however this is unlikely given the slow clearance and metabolism of OMFD in the body. Furthermore, the majority of clear ance occurs during the first several minutes, where the OMFD is distributed into the body. Because this initial distribution occurs predominantly at early times and plasma OMFD levels were stable at 30 to 120 minutes.
The Km:��'m a estimate calculated from the plasma LNAA data (84.3 nmol/mL) was quite close to the av-K Plas m a d . I 8 erage m a pp reporte prevlOus y ( 7.4 nmol/mL; Huang et aI., 1998) . Estimates of Km � ��'m a and Km��� s u c without fixing Km;:��' m a to the plasma-derived value (Eq.
2) resulted in higher values with substantial variability.
However, the ratio of Km ���'m a to Km � �� s u c was the same as that obtained by fixing Km:�� s m a to the plasma derived value. This suggests that, whereas the accuracy of the individual estimates might be somewhat uncertain, the ratio of plasma to tissue Km a pp is robust. Interest ingly, the tissue and plasma Km a pp values are not equal; there is a higher affinity (that is, lower Km � �� s u e ) for brain-to-blood transfer. With Km;:�,;:m a relatively small compared with normal plasma LNAA concentrations, and with both Km���' u c and Km;:��'m a having similar val ues, the DV of OMFD is approximately equal to the tissue-to-plasma ratio of LNAA (Eq. 2).
A potentially useful application of the Km a pp estimates is that, together with plasma LNAA concentrations, the tissue LNAA concentrations can be estimated using only PET and plasma LNAA data (Eq. 4). This technique may enable tissue LNAA concentrations in brain to be esti mated in vivo using noninvasive techniques. The FDOPA Cb DV in Vervel Monkey (Stout et ai, 1998) • DV est. from LNAA in Rat (Glanville & Anderson, 1985) '" DV est. from LNAA in Rat (Voog & Eriksson, 1992) • DV est. from LNAA in Rat (Meloche & Smith 1995) 
Km ;:�� sm a was first derived from plasma data, then sub sequently used to obtain the Km �;�,ue for striatum and cerebellum. These Km app values were used to estimate tissue LNAA concentrations from the PET and blood data. The resulting estimates were not significantly dif ferent from the measured values, though the variability was rather high. Although the Kma pp estimates were de rived and used on the same set of data, they agreed well with those obtained in rats by others (Huang et aI., 1998) . This approach may have some use in the diagnosis of diseases that dramatically change the tissue LNAA con centrations. Individual tissue estimates using the current data, which has a standard deviation of 10% to 12% ± 9%, indicate that only large changes in LNAA con centrations (;::: 20%) would be observable using this method. Further investigation is needed to refine the estimations to provide more sensitive estimates of tissue LNAA concentrations. The concentrations of LNAA and OMFD were ap proximately 10% higher in striatum compared with cer ebellum. This suggests that the cerebellum may slightly underestimate nonspecific uptake when used as a refer ence region for FDOPA kinetic modeling. Experiments in monkeys (Doudet et aI., 199 1) and humans (Wahl et aI., 1994; Dhawan et aI., 1996) suggested a similar find ing, with OMFD having a slightly higher DV in the striatum. However, these groups were not able to estab lish a significant difference using in vivo imaging tech niques, perhaps because of camera resolution and statis tical noise limitations. Slow peripheral OMFD metabolism was observed in rats (-17% per hour), with the formation of a hydrophilic metabolite. This was consistent with other work in mon keys (Doudet et aI., 199 1) , where OMFD metabolites accounted for -13% of plasma radioactivity after 30 min utes. In humans, several investigations have shown little 500 1000 1500 2000
Total Plasma LNAA (nmol/ml) 2500 (5%; Wahl et aI., 1994) or no appreciable metabolite formation (Dhawan et aI., 1996) . Because the OMFD metabolite is highly polar and unlikely to cross the blood-brain barrier, or act as a substrate for the LNAA transporter, the activity associated with the metabolite was subtracted from the plasma in calculations of OMFD distribution volumes. With carbidopa, the amount of plasma metabolite was reduced, but not equal to zero, indicating that: 1) AAAD does not play an important role in metabolite formation, suggesting that OMFD is not decarboxylated into an amine form, which might be trapped in the brain; or 2) peripheral AAAD activity is not completely blocked with the dose of carbidopa ad ministered, even though this dose has been shown to block AAAD activity in FDOP A rat experiments (Mel ega et aI., 199 1). The lack of significant effect of car bidopa on metabolite formation also suggests that this plasma metabolite may also be present in FDOPA ex periments, where significant amounts of OMFD are pe ripherally formed and present in the bloodstream. Plasma LNAA concentrations could potentially affect peripheral OMFD metabolism, however a substantial effect on the distribution volume results is unlikely given the slow OMFD metabolism and constant OMFD concentration at 60 minutes. In addition, the concentration of the metabo lite is not a concern for the current measurements be cause it does not cross the BBB due to its polar nature. Because of the apparent saturation of the LNAA BBB transporter, the distribution volume of OMFD was in versely related to plasma LNAA concentrations. The wide range of normal plasma LNAA concentrations and the associated distribution volume variability suggest that one cannot assume that the DV is constant for la beled LNAA or their analogues. In addition, the distri bution volume of OMFD in rat cerebellum appears to be slightly lower than in the striatum, and therefore may underestimate the nonspecific uptake when used as a reference region in FDOPA kinetic modeling. Estimates of LNAA transport constants for plasma, striatum, and cerebellum were similar to those from other experiments. This raises the possibility that tissue LNAA concentra tions may be estimated using only blood and PET data of an OMFD determination.
